Geethanjali Janga
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
Research Areas
Biography and Research Information
OverviewAI-generated summary
Geethanjali Janga's research focuses on health sciences, with recent publications addressing the economic burden of alternative cancer therapies and diagnostic challenges in immune-mediated red cell aplasia. Janga has a total of two publications, with the most recent in 2026, indicating recent activity in her research pursuits. Her work contributes to the broader understanding of healthcare economics and complex medical diagnoses within the health sciences field.
Metrics
- Publications: 2
Selected Publications
-
MDS-595: Atypical Immune-Mediated Pure Red Cell Aplasia: A Diagnostic Challenge (2026)
-
Economic burden of non-approved alternative therapies among patients with stage IV cancer: A prospective observational study. (2026)
Collaboration Network
Top Collaborators
- Economic burden of non-approved alternative therapies among patients with stage IV cancer: A prospective observational study.
- MDS-595: Atypical Immune-Mediated Pure Red Cell Aplasia: A Diagnostic Challenge
- Economic burden of non-approved alternative therapies among patients with stage IV cancer: A prospective observational study.
- Economic burden of non-approved alternative therapies among patients with stage IV cancer: A prospective observational study.
- Economic burden of non-approved alternative therapies among patients with stage IV cancer: A prospective observational study.
- MDS-595: Atypical Immune-Mediated Pure Red Cell Aplasia: A Diagnostic Challenge
Similar Researchers
Based on overlapping research topics